Home
Firebrick Pharma Ltd
Firebrick starts Phase 3 common cold trial of Nasodine
Business
May 3 2022
3 min read

Firebrick starts Phase 3 common cold trial of Nasodine

news images

Firebrick Pharma Ltd has released a press release.

View Attachment